Results 111 to 120 of about 30,645 (194)

Serum Levels of Interleukin-10 and Interleukin-12 Predict Early, Spontaneous Hepatitis B Virus E Antigen Seroconversion

open access: yes, 2010
This prospective cohort study aimed to determine the effect of cytokines on spontaneous hepatitis B e antigen (HBeAg) seroconversion in patients with chronic hepatitis B virus ( HBV) infection.
WU, JIA-FENG;WU, TZEE-CHUNG;CHEN, CHIEN-HUNG;NI, YEN-HSUAN;CHEN, HUEY-LING;HSU, HONG-YUAN;CHANG, MEI-HWEI   +8 more
core   +1 more source

HBV RNA at 6 months after nucleos(t)ide analogues treatment can predict antiviral efficacy in chronic hepatitis B patients

open access: yesBMC Gastroenterology
Background This multicenter study evaluated serum HBV RNA as a prognostic biomarker for nucleos(t)ide analogue (NA) therapy in chronic hepatitis B (CHB), focusing on correlations with HBV DNA/HBsAg and predictive value for virological response (VR) and ...
Yandi Xie   +14 more
doaj   +1 more source

Hepatitis B core‐related antigen levels after HBeAg seroconversion is associated with the development of hepatocellular carcinoma

open access: yes, 2019
Hepatitis B core‐related antigen (HBcrAg) is a novel serological marker for hepatitis B virus infection. Its clinical significance after HBeAg seroconversion has not been defined.
James Fung   +15 more
core   +1 more source

The mutation profiles/ frequencies of HBeAg seroconversion related mutation nucleotides site in different HBV genotypes.

open access: yes, 2015
P1 represented the statistics difference of certain site mutation ratio between the genotype Band genotype C in children patients.P2represented the statistics difference of certain site mutation ratio between the genotype Band genotype C in adult ...
Xuyang Gong (714919)   +7 more
core   +1 more source

Real-time quantification of hepatitis B virus core-promoter and pre-core mutants during hepatitis E antigen seroconversion

open access: yes, 2004
Background/Aims Detection of hepatitis B virus (HBV) core-promoter A 1762T-G1764A and pre-core G1896A mutants has relied on qualitative assays. We tested the hypothesis that the quantity of A1762T-G1764A and G1896A mutants might have clinical impact, by ...
Kwong, YL   +4 more
core   +1 more source

Profiles of HBV DNA, ALT, and HBeAg status after stopping lamivudine in patients with HBeAg seroconversion

open access: yes, 2007
AIM: To determine the virological and biochemical relapse rates in Chinese CHB patients with lamivudine-induced HBeAg seroconversion after stopping lamivudine therapy, and to identify significant viral or biochemical factors predictive of subsequent ...
Fung, JYY   +6 more
core   +1 more source

Young Chronic Hepatitis B Patients With Nucleos(t)ide Analogue-induced Hepatitis B e Antigen Seroconversion Have a Higher Risk of HBV Reactivation

open access: yes, 2014
Background. It is unclear whether hepatitis B e antigen (HBeAg) seroconversion induced by nucleos(t)ide analogues (NUC) has a prognosis that is similar to that of spontaneous HBeAg seroconversion. Methods.
Tseng, Tai-Chung;Liu, Chun-Jen;Su, Tung-Hung;Yang, Hung-Chih;Wang, Chia-Chi;Chen, Chi-Ling;Kuo, Stephanie Fang-Tzu;Liu, Chen-Hua;Chen, Pei-Jer;Chen, Ding-Shinn;Kao, Jia-Horng   +1 more
core   +1 more source

Home - About - Disclaimer - Privacy